英文名稱 |
中文名稱 |
CAS號 |
操作 |
SC 144 |
吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼 |
895158-95-9 |
詳細(xì)
|
SSR504734 |
2-氯-3-(三氟甲基)-N-((S)-苯基((S)-哌啶-2-基)甲基)苯甲酰胺鹽酸鹽 |
615571-23-8 |
詳細(xì)
|
PF-03463275 |
N-[(3-氯-4-氟苯基)甲基]-1-甲基-N-[[(1ALPHA,5ALPHA,6ALPHA)-3-甲基-3-氮雜雙環(huán)[3.1.0]己烷-6-基]甲基]-1H-咪唑-4-甲酰胺鹽酸鹽 |
1173239-39-8 |
詳細(xì)
|
ASP2535 |
4-[3-(1-Methylethyl)-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole |
374886-51-8 |
詳細(xì)
|
Iclepertin |
BI-425809 |
1421936-85-7 |
詳細(xì)
|
Bitopertin |
(S)-[4-(3-氟-5-三氟甲基吡啶-2-基)哌嗪-1-基][5-(甲磺?;?-2-(2,2,2-三氟-1-甲基乙氧基)苯基]甲酮 |
845614-11-1 |
詳細(xì)
|
BMS-378806 |
1-[(2R)-4-苯甲?;?2-甲基-1-哌嗪基]-2-(4-甲氧基-1H-吡咯并[2,3-B]吡啶-3-基)-1,2-乙二酮 |
357263-13-9 |
詳細(xì)
|
PF-05212384 (PKI-587) |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲 |
1197160-78-3 |
詳細(xì)
|
Firuglipel |
FIRUGLIPEL |
1371591-51-3 |
詳細(xì)
|
GSK1292263 |
GSK1292263 |
1032823-75-8 |
詳細(xì)
|
APD597 |
APD597 |
897732-93-3 |
詳細(xì)
|
APD668 |
APD668 |
832714-46-2 |
詳細(xì)
|
LP-471756 |
化合物 T27850 |
413605-11-5 |
詳細(xì)
|
NCRW0005-F05 |
化合物NCRW0005-F05 |
342779-66-2 |
詳細(xì)
|
TAK-041 |
1929519-13-0 |
1929519-13-0 |
詳細(xì)
|
JNJ-63533054 |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺 |
1802326-66-4 |
詳細(xì)
|
GRK6-IN-2 |
化合物 GRK6-IN-2 |
2677786-27-3 |
詳細(xì)
|
Fluoroorotic Acid, Ultra Pure |
5-氟乳清酸 |
703-95-7 |
詳細(xì)
|
CP21R7 |
GSK-3Β抑制劑(CP21R7) |
125314-13-8 |
詳細(xì)
|
AR-A014418 |
AR-A 014418 |
487021-52-3 |
詳細(xì)
|
BIP-135 |
3-(5-BroMo-1-Methyl-1H-indol-3-yl)-4-(benzofuran-3-yl)pyrrole-2,5-dione |
941575-71-9 |
詳細(xì)
|
BRD0705 |
BRD0705 |
2056261-41-5 |
詳細(xì)
|
SAR502250 |
SAR502250 |
503860-57-9 |
詳細(xì)
|
AZD1080 |
AZD1080 |
612487-72-6 |
詳細(xì)
|
Bisindolylmaleimide I hydrochloride |
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮單鹽酸鹽 |
176504-36-2 |
詳細(xì)
|
AZD2858 |
AZD2858 |
486424-20-8 |
詳細(xì)
|
LY2090314 |
LY 2090314 |
603288-22-8 |
詳細(xì)
|
GSK3-IN-1 |
2-((2-氯芐基)硫基)-5-(吡啶-4-基)-1,3,4-惡二唑 |
478482-74-5 |
詳細(xì)
|
N6022 |
N6022 |
1208315-24-5 |
詳細(xì)
|
Cavosonstat |
CAVOSONSTAT (N91115) |
1371587-51-7 |
詳細(xì)
|
Ezatiostat |
EZATIOSTAT游離的 |
168682-53-9 |
詳細(xì)
|
MitMAB |
N,N,N-三甲基-1-十四烷基溴化銨 |
1119-97-7 |
詳細(xì)
|
CFM 1571 hydrochloride |
CFM 1571 Hydrochloride |
1215548-30-3 |
詳細(xì)
|
Plecanatide acetate |
PLECANATIDE ACETATE |
1075732-84-1 |
詳細(xì)
|
Runcaciguat |
RUNCACIGUAT |
1402936-61-1 |
詳細(xì)
|
(Rac)-MGV354 |
MGV354 |
1852495-86-3 |
詳細(xì)
|
Zagociguat |
ZAGOCIGUAT |
2201048-82-8 |
詳細(xì)
|
CID 16020046 |
4-[4,6-二氫-4-(3-羥基苯基)-3-(4-甲基苯基)-6-氧代吡咯并[3,4-C]吡唑-5(1H)-基]苯甲酸 |
834903-43-4 |
詳細(xì)
|
CVN424 |
Ethanone, 1-[2-[4-(2,4-difluorophenoxy)-1-piperidinyl]-7,8-dihydro-3-[[(3R)-tetrahydro-3-furanyl]amino]pyrido[3,4-b]pyrazin-6(5H)-yl]- |
2254706-21-1 |
詳細(xì)
|
MS48107 |
化合物MS48107 |
2375070-79-2 |
詳細(xì)
|
3-chloro-5-hydroxy BA |
3-氯-5-羥基苯甲酸 |
53984-36-4 |
詳細(xì)
|
GPR84 antagonist 8 |
GPR84 ANTAGONIST 8 |
1445846-30-9 |
詳細(xì)
|
GLPG1205 |
9-(2-環(huán)丙基乙炔基)-2-[((2S)-1,4-二惡烷-2-基甲氧基]-6,7-二氫-4H-嘧啶[6,1-a]異喹啉-4-酮 |
1445847-37-9 |
詳細(xì)
|
GRK5-IN-2 |
化合物GRK5-IN-2 |
1642839-27-7 |
詳細(xì)
|
GRK6-IN-1 |
化合物 GRK6-IN-1 |
2677786-61-5 |
詳細(xì)
|
Linaclotide |
利那洛肽 |
851199-59-2 |
詳細(xì)
|
MM 419447 |
利那洛肽代謝物 |
1092457-78-7 |
詳細(xì)
|
Riociguat |
利奧西呱 |
625115-55-1 |
詳細(xì)
|
GSTO1-IN-1 |
568544-03-6 |
568544-03-6 |
詳細(xì)
|
Ezatiostat hydrochloride |
L-GAMMA-谷氨?;?S-芐基-L-半胱氨?;?2-苯基甘氨酸二乙酯鹽酸鹽 |
286942-97-0 |
詳細(xì)
|
Carboxy pyridostatin trifluoroacetate salt |
CARBOXYPYRIDOSTATIN TRIFLUOROACETATE SALT |
2444713-88-4 |
詳細(xì)
|
CID1231538 |
N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
354126-20-8 |
詳細(xì)
|
NE 52-QQ57 |
2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
1401728-56-0 |
詳細(xì)
|
TP-024 |
化合物FTBMT |
1358575-02-6 |
詳細(xì)
|
PW0787 |
1-(6-(3-氟-5-(三氟甲基)芐基)嘧啶-4-基)-N-(2-羥乙基)吲哚啉-4-甲酰胺 |
2624131-45-7 |
詳細(xì)
|
2-Di-1-ASP |
2-[4-(二甲基氨基)苯乙烯基]-1-甲基吡啶碘化物 |
2156-29-8 |
詳細(xì)
|
BMVC2 |
o-BMVC |
850559-51-2 |
詳細(xì)
|
MM41 |
化合物 MM41 |
1429028-96-5 |
詳細(xì)
|
Inarigivir ammonium |
INARIGIVIR銨 |
2172788-92-8 |
詳細(xì)
|
Morphothiadin |
莫非賽定 |
1092970-12-1 |
詳細(xì)
|
Vebicorvir |
ABI-H0731 |
2090064-66-5 |
詳細(xì)
|
AB-423 |
AB-423 |
1572510-80-5 |
詳細(xì)
|
JNJ-632 |
JNJ-632 |
1572510-42-9 |
詳細(xì)
|
RG7834 |
RO 7020322 |
2072057-17-9 |
詳細(xì)
|
Torcitabine |
2'-脫氧-L-胞苷 |
40093-94-5 |
詳細(xì)
|
NVR 3-778 |
4-fluoro-3-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide |
1445790-55-5 |
詳細(xì)
|
HBF-0259 |
Tetrazolo[1,5-a]pyrimidine, 7-(2-chloro-6-fluorophenyl)-5-(4-chlorophenyl)-1,5,6,7-tetrahydro- |
957011-15-3 |
詳細(xì)
|
Tenofovir amibufenamide |
艾米替諾福韋 |
1571076-26-0 |
詳細(xì)
|
Bicyclol |
雙環(huán)醇 |
118159-48-1 |
詳細(xì)
|
Osalmid |
柳胺酚 |
526-18-1 |
詳細(xì)
|
Telbivudine |
替比夫定 |
3424-98-4 |
詳細(xì)
|
Merimepodib |
MERIMEPODIB |
198821-22-6 |
詳細(xì)
|
ABT-072 |
1132936-00-5 |
1132936-00-5 |
詳細(xì)
|
ABT-072 potassium trihydrate |
ABT-072 POTASSIUM TRIHYDRATE |
1132940-31-8 |
詳細(xì)
|
MK-0608 |
(2R,3R,4R,5R)-2-(4-氨基-7H-吡咯并[2,3-D]嘧啶-7-基)-5-(羥甲基)-3-甲基四氫呋喃-3,4-二醇 |
443642-29-3 |
詳細(xì)
|
Taribavirin hydrochloride |
TARIBAVIRIN HYDROCHLORIDE |
40372-00-7 |
詳細(xì)
|
Inarigivir soproxil |
INARIGIVIR SOPROXIL |
942123-43-5 |
詳細(xì)
|
Valopicitabine dihydrochloride |
Valopicitabine dihydrochloride |
640725-71-9 |
詳細(xì)
|
Ombitasvir |
奧比他韋 |
1258226-87-7 |
詳細(xì)
|
ITMN 4077 |
((2R,6S,13AS,14AR,16AS,Z)-14A - ((環(huán)丙基磺?;?氨基甲?;?-2- |
790305-05-4 |
詳細(xì)
|
Beclabuvir |
Beclabuvir |
958002-33-0 |
詳細(xì)
|
EIDD-1931 |
N-羥基胞苷 |
3258-02-4 |
詳細(xì)
|
Paritaprevir |
ABT450 |
1216941-48-8 |
詳細(xì)
|
Phen-DC3 Trifluoromethanesulfonate |
929895-45-4 |
929895-45-4 |
詳細(xì)
|
2'-C-Methyladenosine |
2'-C-甲基腺苷 |
15397-12-3 |
詳細(xì)
|
Ledipasvir-d6 |
|
2050041-12-6 |
詳細(xì)
|
Ledipasvir (acetone) |
雷迪帕韋單丙酮溶劑化物 |
1441674-54-9 |
詳細(xì)
|
HCV-IN-30 |
達(dá)卡他韋中間體II |
1007882-23-6 |
詳細(xì)
|
HCV-IN-31 |
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
1998705-62-6 |
詳細(xì)
|
BMS-986094 |
N-(2'-C-甲基-6-O-甲基-P-1-萘基-5'-鳥苷?;?-L-丙氨酸 2,2-二甲基丙酯 |
1234490-83-5 |
詳細(xì)
|
Sofosbuvir impurity M |
索非布韋雜質(zhì)M |
2095551-10-1 |
詳細(xì)
|
Bemnifosbuvir hemisulfate |
AT-527 |
2241337-84-6 |
詳細(xì)
|
DDX3-IN-1 |
DDX3-IN-1 |
1919828-83-3 |
詳細(xì)
|
Samatasvir |
ATOLIHZIXHZSBA-BTSKBWHGSA-N |
1312547-19-5 |
詳細(xì)
|
EIDD-2749 |
4'-C-Fluoro-uridine |
1613589-24-4 |
詳細(xì)
|
Bemnifosbuvir |
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester |
1998705-64-8 |
詳細(xì)
|
Furaprofen |
呋喃洛芬 |
67700-30-5 |
詳細(xì)
|
NIM811 |
NIM811 |
143205-42-9 |
詳細(xì)
|
Voxilaprevir |
維昔普維 |
1535212-07-7 |
詳細(xì)
|
2'-O-Methylcytidine |
2'-甲氧基胞苷 |
2140-72-9 |
詳細(xì)
|